LABU

Direxion Daily S&P Biotech Bull 3X Shares
NYSEArcaUSDETF / FUND DELAYED
Last price
232.00
▼ 25.38 (9.86%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
255.87
Prev close
257.38
Day high
260.26
Day low
224.76
Volume
997.84K
Market cap
—
P/E (TTM)
—
52W range
102.36 – 341.93

Day trading desk

Current session · delayed
Gap from prior close
-0.59%
Prior close 257.38
VWAP
233.07
-0.46% from price
Relative volume
5.10×
Unusually busy
Session range
16.86%
224.66 – 262.54
Position in range
19%
Near session low
ATR (14D)
22.02
9.49% of price
Prior day high
259.09
PDH
Prior day low
239.49
PDL
Bid / ask spread
—
Quote not published
Session volume
1.99M
Avg 390.51K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-11.51% -13.5%
1M
-23.92% -25.1%
3M
-27.19% -31.7%
6M
+35.53% +17.4%
YTD
+44.90% +30.6%
1Y
+123.62% +107.2%
3Y
+203.08% +120.8%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

1 shown · by weight
SymbolNameWeight
TWST Twist Bioscience Corp 0.55%

Sector exposure

Fund weightings
Healthcare
99.28%
Financial services
0.72%

Fund profile

As reported
Fund familyDirexion Funds
CategoryTrading--Leveraged Equity
Legal typeExchange Traded Fund
Expense ratio0.96%
Turnover107.0%
Total net assets$7.48M

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on LABU open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
0.77
Call-heavy session
Put / call open interest
1.60
Positioning, not flow
Max pain
250.00
+8.2% from spot
ATM implied vol
104.6%
Nearest strike to spot
Skew (10% OTM)
+0.9%
Puts bid over calls
Call volume
1.87K
Contracts, this expiry
Put volume
1.44K
Contracts, this expiry
Heaviest call OI
270.00
362 contracts
Heaviest put OI
225.00
326 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
253.64
-8.53% from price
SMA 20
260.24
-11.26% from price
SMA 50
275.61
-16.20% from price
SMA 100
250.52
-7.39% from price
SMA 200
210.81
+9.55% from price
EMA 12
255.69
-9.27% from price
EMA 26
265.33
-12.56% from price
EMA 50
266.84
-13.06% from price
RSI (14)
38.0
Neutral
MACD (12,26,9)
-9.64
Hist -2.13
ATR (14)
22.02
9.53% of price
Realised vol 30D
81.8%
Annualised
Bollinger upper
284.53
20, 2σ
Bollinger lower
235.95
20, 2σ
50 / 200 cross
Golden
275.61 vs 210.81
Trend bias
Above 200
+9.55%

Options chain

Account required
Expiry
Spot 232.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
3.07
More volatile than market
Correlation to SPY
0.47
Loosely linked
Realised vol 30D
81.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-32.4%
Peak to trough
Max drawdown 5Y
-97.1%
Peak to trough
ATR 14
22.02
9.53% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.